Alleviant Medical website screenshot

Alleviant Medical

Alleviant Medical, Inc. is a clinical-stage medical device company headquartered in Austin, Texas, founded in 2017 to develop minimally invasive, transcatheter therapies for heart failure. The Alleviant System is an investigational, no-implant approach that creates a small interatrial passageway to relieve elevated left atrial pressure without leaving a permanent device behind; it holds U.S. FDA Breakthrough Device designation for both preserved and reduced ejection fraction heart failure and is under study in the FDA-approved ALLAY-HF and ALLAY-HFrEF pivotal trials. The company has raised roughly $164M across a $75M round led by S3 Ventures and RiverVest Venture Partners and a $90M round led by Gilde Healthcare with Omega Funds, Vensana Capital, Longview Ventures, Gilmartin Capital and the TMC Venture Fund. Alleviant is a device and clinical-trial business, not a software business: it publishes no developer portal, no public API, no SDK and no machine-readable specification, and its public web surface is limited to clinician, patient-education, investor and press material.

Alleviant Medical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Cardiology, and Heart Failure.

Alleviant Medical’s developer surface includes engineering blog and 15 more developer resources.

11.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesHealth CareCardiologyHeart FailureInterventional CardiologyClinical TrialsMedical TechnologyLife SciencesAustinTexas

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 11.5/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alleviant-medical: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Alleviant Medical Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 5

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: alleviant-medical
name: Alleviant Medical
description: 'Alleviant Medical, Inc. is a clinical-stage medical device company headquartered in Austin, Texas, founded in
  2017 to develop minimally invasive, transcatheter therapies for heart failure. The Alleviant System is an investigational,
  no-implant approach that creates a small interatrial passageway to relieve elevated left atrial pressure without leaving
  a permanent device behind; it holds U.S. FDA Breakthrough Device designation for both preserved and reduced ejection fraction
  heart failure and is under study in the FDA-approved ALLAY-HF and ALLAY-HFrEF pivotal trials. The company has raised roughly
  $164M across a $75M round led by S3 Ventures and RiverVest Venture Partners and a $90M round led by Gilde Healthcare with
  Omega Funds, Vensana Capital, Longview Ventures, Gilmartin Capital and the TMC Venture Fund. Alleviant is a device and clinical-trial
  business, not a software business: it publishes no developer portal, no public API, no SDK and no machine-readable specification,
  and its public web surface is limited to clinician, patient-education, investor and press material.'
image: https://alleviantmedical.com/logo.svg
url: https://raw.githubusercontent.com/api-evangelist/alleviant-medical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Medical Devices
- Health Care
- Cardiology
- Heart Failure
- Interventional Cardiology
- Clinical Trials
- Medical Technology
- Life Sciences
- Austin
- Texas
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/alleviant-medical-domain-security.yml
- type: Website
  url: https://alleviantmedical.com
- type: Product
  url: https://alleviantmedical.com/hf-shunt-therapy
- type: HealthcareProfessionals
  url: https://alleviantmedical.com/healthcare-professionals
- type: ClinicalTrials
  url: https://alleviantmedical.com/allay-hf
- type: Blog
  url: https://alleviantmedical.com/press-resources
- type: PressReleases
  url: https://alleviantmedical.com/press-resources
- type: Locations
  url: https://alleviantmedical.com/find-a-center
- type: Patents
  url: https://alleviantmedical.com/patents
- type: TermsOfService
  url: https://alleviantmedical.com/terms-and-conditions
- type: PrivacyPolicy
  url: https://alleviantmedical.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/alleviant-medical/
- type: Twitter
  url: https://x.com/alleviant
- type: Facebook
  url: https://www.facebook.com/alleviantmedical
- type: SecondaryMarket
  url: https://forgeglobal.com/alleviant-medical_stock/
- type: LLMsTxt
  url: llms/alleviant-medical-llms.txt
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Alleviant Medical is a clinical-stage cardiac device company whose product is an investigational transcatheter shunt
    procedure, not software, so there is nothing to expose as an API; alleviantmedical.com is a 25-page clinician and patient-education
    site with no /developers or /api path and no api./docs./developer. subdomain resolving in DNS at all.
  evidence:
  - url: https://alleviantmedical.com/developers
    status: 404
  - url: https://alleviantmedical.com/openapi.json
    status: 404
  - url: https://alleviantmedical.com/llms.txt
    status: 404
  - url: https://alleviantmedical.com/.well-known/agent-card.json
    status: 404
  - url: https://alleviantmedical.com/.well-known/security.txt
    status: 404
  - url: https://api.alleviantmedical.com/openapi.json
    status: 0
  checked: '2026-08-06'